Conference News

AACR 2021 Leveraging the Microbiome to Enhance Cancer Treatment Andrea Facciabene, PhD, and colleagues conducted a preclinical study in which vancomycin enhanced the efficacy of radiotherapy against melanoma and lung cancer.
News, April 19, 2021
AAN 2021 Intranasal Third-Generation CGRP Effective for Acute Migraine Intranasal zavegepant, a third-generation calcitonin gene-related peptide receptor agonist, is effective and well tolerated in the treatment of acute migraine, new research shows.
News, April 19, 2021
NFK 2021 20% of Dialysis Patients Are Hesitant About COVID-19 Vaccine An early 2021 survey of a representative sample of 1515 US patients treated with hemodialysis showed that one fifth had some level of hesitancy about receiving a COVID-19 vaccine.
News, April 19, 2021
AAN 2021 Stroke 'Not a Common Complication' in COVID-19: New Studies Two new large studies show stroke rates in hospitalized patients with COVID-19 ranging from 1.5% to 2.2%, lower than originally thought. One also reports a reduction in stroke care during the pandemic.
News, April 18, 2021
AAN 2021 Common MS Treatment Wears Off More Quickly in Black Patients Black patients with multiple sclerosis or neuromyelitis optica spectrum disorder may respond differently to a common MS therapy compared to their White peers, new research suggests.
News, April 17, 2021
EPA 2021 Serious, 'Unexpected' Adverse Events From Nasal Esketamine Intranasal esketamine is linked to a greater risk for serious and unexpected adverse events vs other antidepressants. However, the weight of evidence suggests it is not a major concern, an expert notes.
News, April 16, 2021
AACR 2021 Tebentafusp improves OS: A First in Metastatic Uveal Melanoma First-line tebentafusp significantly improved overall survival (OS) when compared with immunotherapy or chemotherapy in patients with metastatic uveal melanoma in a phase 3 trial.
News, April 16, 2021
AAN 2021 MS Hospital Visits Increase in Warmer Weather The authors of a new study warn that global warming could have serious implications for people living with multiple sclerosis and for healthcare usage.
News, April 15, 2021
AAN 2021 COVID-Related Syndrome Tied to Neurologic Symptoms in Kids Approximately half of children with pediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 had new-onset neurologic symptoms.
News, April 15, 2021
AACR 2021 Personalized Cancer Vaccine Shows Early Promise Across Tumor Types In a phase 1 trial, the vaccine, called PGV-001, was well tolerated. It was given to 13 patients with multiple myeloma who had a high risk of recurrence after surgery or autologous stem cell transplant.
News, April 15, 2021
AACR 2021 Healthy Lifestyle May Offset Genetic Risk in Prostate Cancer Adhering to a healthy lifestyle may offset the heightened risk of lethal prostate cancer in patients with adverse genetic risk factors, according to results of a large US study presented at AACR 2021.
News, April 15, 2021
AACR 2021 Made-to-Order TILs Effective Against Metastatic Melanoma Cell therapy with tumor-infiltrating lymphocytes (TILs) extracted from tumor tissue yielded responses in patients with heavily pretreated malignant melanoma.
News, April 15, 2021
AACR 2021 New Combo Shows Benefit Even in Patients With High-Risk HCC Updated data from the IMBRave150 trial show benefit for the combination of atezolizumab with bevacizumab even in patients with high-risk hepatocellular carcinoma.
News, April 14, 2021
ENDO 2021 Cushing Death Rate 'Unacceptable' In the largest such study to date, death rates among patients with endogenous Cushing syndrome have dropped since 2000 but are still threefold that of the general population.
News, April 14, 2021
AACR 2021 New Data Dim Hopes for 'Triumph of Drug Discovery' Excitement over novel drugs that for the first time showed efficacy against KRAS mutations has been muted somewhat by new data showing many different types of resistance mechanisms.
News, April 14, 2021
EPA 2021 Adjunctive MDMA Safe, Effective for Severe PTSD Severe posttraumatic stress disorder (PTSD) symptoms may significantly improve after adding MDMA to psychotherapy, results from the phase 3 MAPP1 trial suggest; but treatment context is crucial.
News, April 14, 2021
AACR 2021 Combo Provides 'Broad Benefit' Across NHL Subtypes The combination of copanlisib + rituximab led to a reduction in the risk for disease progression/death when compared with rituximab + placebo in patients with relapsed, indolent non-Hodgkin lymphoma.
News, April 13, 2021
EPA 2021 New Global Telepsychiatry Guidelines Released Prompted by the worldwide explosion of interest in telepsychiatry driven by the COVID-19 pandemic, the guidelines outline the need for, and a vision of, international collaboration in psychiatry.
News, April 13, 2021
NFK 2021 Task Force Reviewing Race Modifier in eGFR Issues Interim Report Task force of the National Kidney Foundation and American Society of Nephrology formed to reassess the race coefficient for calculating eGFR releases progress report, promises recommendations soon.
News, April 13, 2021
What's the Future of Telehealth? It's 'Complicated' The use of telehealth may have skyrocketed during the COVID-19 pandemic, but it also exposed a digital divide, speaker after speaker said during a panel discussion at the Society for Pediatric Dermatology pre-AAD meeting.
News, April 12, 2021

No Results